Non-small cell lung cancer and elevated eosinophil count: A case report and literature review

Rohit Venkatesan , Amir Salam , Issam Alawin , Maurice Willis
{"title":"Non-small cell lung cancer and elevated eosinophil count: A case report and literature review","authors":"Rohit Venkatesan ,&nbsp;Amir Salam ,&nbsp;Issam Alawin ,&nbsp;Maurice Willis","doi":"10.1016/j.ctrc.2015.05.002","DOIUrl":null,"url":null,"abstract":"<div><p>In earlier work it was unclear whether there was any true prognostic value when high numbers of eosinophils were seen in the peripheral blood of lung cancer patients. As time passed, it became somewhat clearer that this occurrence may correlate with a poor prognosis in these patients. These ideas reflected what we came to know about the pathophysiology of hypereosinophilia in the blood in this setting. With paraneoplastic processes and distant metastases (to the bone marrow) thought to function at least in part as the mechanism of hypereosinophilia in these patients, it became more evident why these patients tended to have a poorer prognosis. However interestingly and paradoxically, there also has been work indicating that this occurrence may actually be protective against metastatic disease.</p><p>Here, we present the case of a sixty year old Caucasian female who presented with non-small cell lung cancer (NSCLC), diffusely metastatic at presentation, who also presented with hypereosinophilia which proved to be a poor prognostic indicator in this case.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2015.05.002","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213089615000183","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

In earlier work it was unclear whether there was any true prognostic value when high numbers of eosinophils were seen in the peripheral blood of lung cancer patients. As time passed, it became somewhat clearer that this occurrence may correlate with a poor prognosis in these patients. These ideas reflected what we came to know about the pathophysiology of hypereosinophilia in the blood in this setting. With paraneoplastic processes and distant metastases (to the bone marrow) thought to function at least in part as the mechanism of hypereosinophilia in these patients, it became more evident why these patients tended to have a poorer prognosis. However interestingly and paradoxically, there also has been work indicating that this occurrence may actually be protective against metastatic disease.

Here, we present the case of a sixty year old Caucasian female who presented with non-small cell lung cancer (NSCLC), diffusely metastatic at presentation, who also presented with hypereosinophilia which proved to be a poor prognostic indicator in this case.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
非小细胞肺癌与嗜酸性粒细胞升高:1例报告及文献复习
在早期的研究中,当肺癌患者外周血中出现大量嗜酸性粒细胞时,是否有任何真正的预后价值尚不清楚。随着时间的推移,越来越清楚的是,这种情况可能与这些患者的预后不良有关。这些想法反映了我们在这种情况下对血液中嗜酸性细胞增多症的病理生理学的了解。由于副肿瘤进程和远处转移(骨髓)被认为至少在一定程度上是这些患者嗜酸性粒细胞增多的机制,因此这些患者倾向于预后较差的原因变得更加明显。然而,有趣和矛盾的是,也有研究表明,这种情况实际上可能对转移性疾病有保护作用。在这里,我们提出一个60岁的白人女性,她表现为非小细胞肺癌(NSCLC),弥漫性转移,她也表现为嗜酸性粒细胞增多,在这种情况下,嗜酸性粒细胞增多被证明是一个不良的预后指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice Activity of trastuzumab-emtansine (TDM1) in HER2-positive breast cancer brain metastases: A case series Pigmentation of the tongue with lapatinib treatment in a patient with advanced breast cancer: A case report Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational study Multiple nodular lung metastases with no obvious primary showing low positive 18-fluoro deoxyglucose (FDG) uptake on positron emission tomography (PET) scan: A unique case of metastatic ameloblastoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1